Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
25-dihydroxyvitamin D₃
- Development stage
- Preclinical
- Modality
- Small Molecules
- Administration
- Oral, Intravenous, Topical
01
Overview
25-dihydroxyvitamin D₃ is a non-standard chemical name. The chemically correct forms are 25-hydroxyvitamin D₃ (calcifediol), which is a precursor to the active form of vitamin D, and 1,25-dihydroxyvitamin D₃ (calcitriol), the active hormonal form. In the context of pregnancy-induced hypertension and preeclampsia, lower levels of 25-hydroxyvitamin D have been associated with these conditions.
- Other names
- 25-hydroxyvitamin D25(OH)D
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on 25-dihydroxyvitamin D₃.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 25-dihydroxyvitamin D₃.